iQtech Closes First Investment Round to Accelerate AI-Powered EsculapioVR Platform
Qatar-based iQtech, a company specializing in advanced medical simulation and cross-reality (XR) technologies, has announced the successful closing of its first investment round in partnership with Selexi and Yuniro, marking a strategic step toward accelerating growth and advancing its technological solutions.
The company’s core focus centers on EsculapioVR, an AI-powered medical training and assessment platform that integrates immersive 3D simulations with intelligent performance evaluation systems. The platform aims to redefine medical education by delivering highly realistic training environments and advanced assessment methodologies that move beyond conventional teaching models.
The investment round received backing from Selexi, a European specialist in computer-based assessment solutions, and Yuniro, a deep-tech company active between Italy and Qatar. Their participation strengthens iQtech’s capabilities in assessment automation and intelligent simulation platform development.
- Successful closing of iQtech’s first funding round with Selexi and Uniero.
- Acceleration of EsculapioVR’s AI-driven development roadmap.
- Infrastructure enhancement and expansion across Qatar and the MENA region.
- Added expertise in assessment automation and intelligent simulation systems.
The funding will support infrastructure strengthening, domestic expansion within Qatar, and future growth across the Middle East and North Africa (MENA).
iQtech originated within the ecosystem of Qatar Science & Technology Park (QSTP), whose supportive environment contributed to this funding milestone.
Founded in 2025, iQtech develops high-fidelity AI-powered simulation solutions designed to bridge the gap between academic education and operational excellence, serving medical, civil, and military sectors.
